In this economy we all need to be innovators in this industry and elevate our level of performance. We must collectively publish our educational outcomes data, but, even more importantly, we must have meaningful data to publish. Our success stories must be showcased at national meetings and receive the media attention they deserve. Only then can we assume our place as catalysts for improvements in healthcare delivery.
On a daily basis, we meet individuals who have been silently touched by CME. The woman walking in the street who would have been debilitated by severe asthma, the custodian whose rheumatoid arthritis is in remission and can still work, and even closer to home — the beloved family member who, in her battle against advanced lung cancer, has responded to new therapies when standard chemotherapy had failed. In each instance, off-label use of agents, which is openly discussed in CME activities, has dramatically improved the lives of these individuals. These stories are now commonplace because of industry, government, and foundation support that has led to increased availability of CME. As providers, we must all work harder to ensure that clinicians continue to receive cutting-edge CME that addresses their validated educational needs, and that the benefits of CME to society are transparent to all. Perhaps Mahatma Gandhi said it best: “Be the change you want to see in the world.” Let's all heed that call.
This post has been adapted from the original article that appears in the citation below
http://meetingsnet.com/cmepharma/cme/meetings_fight_cme/
The views expressed in this Blog are my own and do not necessarily reflect the views of Science Care.
Blog Directory
Soy CandlesCandles
Top Stories
No comments:
Post a Comment